Intended Use The 4th Generation HIV TRI-DOT + Ag test is a visual, rapid, sensitive and accurate immunoassay for the differential detection of HIV-1 p24 antigen and HIV-1 & HIV-2 antibodies (IgM,IgG & IgA) in Human Serum or Plasma. The test is a screening test for p24 antigen (HIV-1), anti-HIV-1 & anti-HIV-2 and is for in vitro diagnostic use only. It is intended for screening of blood donors or other individuals at risk for HIV-1 & HIV-2 infection and for clinical diagnostic testing. Salient Features Rapid visual test ,based on enzyme immuno assay & Flow Through Technology. Rapid test for simultaneous and differential detection of p24 Antigen & antibodies for HIV on the same device. Ideal for Blood screening: detects sero-negative HIV Cases. Use of gp-41, C terminus of gp120 for HIV-1 antibodies & gp-36 for HIV -2 antibodies. Detection of Group ‘0’ & subtype ‘C’ of HIV-1, which is most prevalent in India. Unique washing steps for clear Interpretation of Results. Evaluated by National Institute of Biologicals- 100 % Sensitivity & 100 % Specificity. Long Shelf life: 15 months at 2-8° C.

Intended Use Advantage Typhi IgM & IgG Card is a rapid solid phase immuno-chromatographic test for the qualitative differential and simultaneous detection of salmonella typhi (S. typhi) IgM and IgG antibodies in human serum / plasma. This test is for in vitro diagnostic use only and is intended as an aid in the earlier diagnosis of typhoid infection and in the determination of recent and past infection. Salient Features Rapid qualitative test for differential detection of Salmonella typhi (S.typhi) IgM and IgG Antibodies in Human Serum / Plasma Determination of both recent and past infection Results within 20 minutes Bio-hazard free, fully covered, see-through Device Simple & Easy to use Test Procedure No Instruments required Long Shelf Life: 30 months at 2-30ºC Convenient Pack size: 50 Tests

Since the company was founded, Mindray has been continuously exploring new ways to improve diagnostic confidence. Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings ultrasound image quality to a higher level by zone acquisition and channel data processing. As well as the premium level image quality, Resona 7 also enhances clinical research capabilities with the revolutionary V Flow for vascular hemodynamic evaluation, and the most intelligent plane acquisition from 3D datasets for fetal CNS diagnosis. Combining the most intuitive gesture-based multi-touch operation and all the essential clinical features, Resona 7 is truly leading new waves in ultrasound innovation. With core platform advantages of ZST+ The channel data based ZST+ is an extraordinary innovation, representing an ultrasound evolution. Transforming ultrasound metrics from conventional beamforming to channel data based processing, ZST+ is able to deliver multiple imaging advances: Advanced Acoustic Acquisition, Dynamic Pixel Focusing, Sound Speed Compensation, Enhanced Channel Data Processing and Total Recall Imaging. Advanced features V Flow V Flow (Vector Flow) is a novel approach for vascular hemodynamic analysis. V Flow uses color coded vector arrows to indicate the velocity’s magnitude and direction of blood cells. With ultra-high frame rates, it provides extremely accurate and angle-independent visualization of complex vascular hemodynamic profiles. With comprehensive data information, V Flow is the most valuable tool for vascular clinical research. resona-7-fig3-1-pc UWN+ Contrast Imaging UWN+ (Ultra-Wideband Non-linear Plus) CEUS enables the Resona 7 to detect and utilize both the 2nd harmonic and non-linear fundamental signals, generating significantly enhanced images, resulting in greater sensitivity of minor signals and longer agent duration with lower MI. Forwarding smart to clinical intelligence The Resona 7 elevates clinical intelligence with a complete solution that enables clinicians to manage both routine and advanced studies more efficiently,consistently, and accurately, from acquisition to calculation. As an example, Smart Planes CNS shows exceptional intelligence in accurate diagnosis and analysis of the fetal central nervous system (CNS) Smart Planes CNS Mindray’s exclusive pioneering technology positions the Resona 7 as the industry’s first ultrasound system to allow fully automatic and accurate detection of the most significant planes and frequently used measurements of fetal CNS, leading to intelligent diagnosis, improved throughput, and reduced user dependence. Smart Planes CNS provides a user-friendly tool that greatly improves scanning efficiency through increased accuracy coupled with automated operation. With a simple button click on a 3D fetal brain volume image, the standard CNS scanning planes (MSP, TCP, TTP and TVP) and a range of related anatomical measurements (BPD, HC, OFD, TCD, CM and LVW) are obtained immediately. Smart Face Acquiring an optimal view of the fetal face in 3D ultrasound is cumbersome and time-consuming. In some cases, it is impossible to get rid of the occlusions such as cord, placenta, uterus and extremities. The new Resona 7 with Zone Intelligence provides a fast and intelligent optimization for fetal face with simply one-touch. It can immediately remove occlusions in the volume data, eliminate unwanted noise information, and generate an optimal view of the fetal face with minimal effort. Ergonomics The Resona 7 is designed around you. Gesture-based operation opens up a new trend in cart-based ultrasound with an agile, smart, and intuitive user experience beyond your expectations. Gel warmer’s three level temperature and swiveling angle adjustment of the control panel delivers great patient comfort and user convenience.

In compliance with out-of-hospital patient transport standards such as EN1789, EN13718-1, IEC60601-1-12 and U.S. military standards, N1 is a highly competent solution for various out-of-hospital transport settings both on land and in air. The N1's exceptional reliability and strong performance enhance your confidence to provide seamless patient care during transport no matter intra or out of hospital. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. benevision-n1-fig2-1-pc BeneVision N1 as a Multi-Parameter Module Slide directly into the module slot or SMR of the N-Series monitor providing an expansive set of parameter measurements. When combined with our additional advanced parameter modules, this solution fits even the highest level of critical care environments. benevision-n1-fig2-3-pc Companion Mode Connect with N-Series host monitor via cable connection to N1 dock and have the ability for dual-screen monitoring and bi-directional control of the bedside monitor - expanding slot space for more advanced parameters and enhanced ICU workflow. Patient-Centric Data Collection When connected to a bedside patient monitor, advanced parameters collected from the host monitor such as AG and BIS, etc., will also be stored in N1 with trend data and alarm events reviewable even when it is disconnected.

With state-of-the-art screen technology, BeneVision N Series patient monitors deliver clear, multi-color, wide-format displays for users to capture and review information at a glance. With multi-touch operation, users can control the monitor and review patient data quickly and easily. BeneVision N Series provides the world's best monitoring technologies for you, with new applications being developed. Perfect hemodynamic monitoring solution, not only provides a variety of measurement methods, ICG, PiCCO, ScvO2, C.O., but also provides comprehensive analysis tool – HemoSight™. HemoSight™ focuses on hemodynamic treatment process, and provides appropriate tools for each stage. Advanced modular regional tissue oxygenation measurement -- INVOS rSO2. Volumetric capnography & metabolic measurement help to evaluate the adequacy of ventilation and determine the ventilator setting effectively, and improve the safety of weaning and extubation. Powerful Clinical Assistive Applications (CAAs) to support efficient decision making when time is critical. Each CAA focuses on major clinical workflow challenges that individual departments face. Solutions optimized for each point of care At every point of care, such as ICU, CCU, NICU, OR, PACU, ER, BeneVision N Series patient monitors always provide a suitable solution to meet your clinical needs for monitoring your patient's status anywhere, anytime, even on your way through mobile devices. With excellent transport solution, BeneVision N Series patient monitor brings a smooth workflow and safe data management through the entire care process. BeneVision takes less time to operate, and helps you understand the patient's variables quickly. With HL7,BeneVision N Series patient monitors can directly connect to the hospital clinical network.BeneVision N12 is capable of monitoring multiple parameters simultaneously both at bedside and during transport. IT structure designed for seamless connectivity Mindray patient monitoring system incorporates extensive network adaptability to integrate with the hospital's current network infrastructure, ensuring that critical data is on hand for clinical decision making - and is integrated with the patient record. Mindray's central station and eGateway further enhances the connectivity of BeneVision to your clinical world. Bedside devices data and other clinical systems data are shared to support your diagnosis and clinical decisions.

The OnSite TB IgG/IgM Combo Rapid Test is a lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of IgM anti-Mycobacterium tuberculosis (anti-M. TB) and IgG anti-M. TB in human serum, plasma or whole blood. A lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of IgM and IgG anti-Mycobacterium tuberculosis (anti-M. TB) in human serum, plasma or whole blood. Individually sealed foil pouches containing: One cassette device One desiccant Plastic droppers Sample diluent (REF SB-R0053, 5 mL/bottle) One package insert (instruction for use) CTK Products at a Glance Flyer Inserts TB-HIV Rapid Test Presentation U.S. CDC Tuberculosis Homepage: About Tuberculosis WHO-Tuberculosis Fact sheets The World TB Day newsletter

The OnSite Leptospira IgG/IgM Combo Rapid Test is a lateral flow chromatographic immunoassay that can be performed within 15-20 minutes by minimally skilled personnel, and without the use of laboratory equipment. This test is intended to be used for the simultaneous detection and differentiation of IgG and IgM antibodies to Leptospira interrogans (L. interrogans) in human serum, plasma or whole blood. It is intended to be used as a screening test by professionals, and provides a preliminary test result to aid in the diagnosis of infection with L. interrogans. Any interpretation or use of this test result must also rely on other clinical findings as well as on the professional judgment of health care providers. Recommended for use: Any person presenting with clinical signs or symptoms consistent with acute infection with interrogans including: high fever, headache, chills, muscle aches, vomiting, jaundice, red eyes, abdominal pain, diarrhea, skin rash After exposure to a known contaminated source Accuracy: 100% specificity and 100% sensitivity in comparison with a reference rapid test on the market Cross Reactivity: No false positive results were observed on specimens from TP, HIV, Dengue, TB, Typhoid Ab , HBsAg, HCV Ab, HEV Ab, H.P Ab, HAV, HCG, RF, ANA, HAMA Interference: No interference were seen with substances: Salicylic acid: 4.34 mmol/L; Glucose: 55 mmol/L; Sodium citrate: 3.8 %; Heparin: 3,000 U/L; Creatinine: 442 μmol/L; Bilirubin: 20 mg/dL; EDTA: 3.4 μmol/L; Hemoglobin: 2g/L; Human IgG: 1000 mg/dL; AlbuminL 60 g/L Shelf life: 24 month Individually sealed foil pouches containing: One cassette device One desiccant 5 μL capillary tubes Sample diluent (REF SB-R0101, 5 mL/bottle) One package insert (instruction for use) CTK Products at a Glance Inserts U.S. CDC Leptospira Homepage: About Leptospira WHO: Leptospirosis Fact Sheets

The OnSite Malaria Pf/Pv Ab Combo Rapid Test is a lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of antibodies including IgG, IgM and IgA to Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) in human serum, plasma or whole blood. Uses serum, plasma or whole blood specimens Utilizes highly purified antigen to ensure test sensitivity and specificity Detects total antibodies to Pf and Pv Ease of use, requires minimal training of personnel Quick turnaround time to results Individually sealed foil pouches containing: One cassette device One desiccant Two-mark capillary tubes (10/20 µL) Sample diluent (REF SB-R0111, 5 mL/bottle) One package insert (instruction for use) CTK Products at a Glance Flyer Inserts Malaria Pf/Pv Ag Rapid Test Presentation Malaria Pf/Pan Ag Rapid Test Presentation Poster U.S. CDC Malaria Homepage: About Malaria WHO: Malaria Fact Sheets

The OnSite Dengue IgG/IgM 3.0 Combo Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG and IgM anti–dengue virus (DEN1, 2, 3 and 4) in human serum, plasma or whole blood. Utilizes recombinant chimeric dengue virus licensed from the US CDC Detects all four dengue serotypes IgM detection indicates recent infection IgG detection indicates recent or previous infections Individually sealed foil pouches containing: One cassette device One desiccant 5 µL capillary tubes Sample diluent (REF SB-R0061, 5 mL/bottle) One package insert (instruction for use)Individually sealed foil pouches containing: One cassette device One desiccant 5 µL capillary tubes Sample diluent (REF SB-R0061, 5 mL/bottle) One package insert (instruction for use)Individually sealed foil pouches containing: One cassette device One desiccant 5 µL capillary tubes Sample diluent (REF SB-R0061, 5 mL/bottle) One package insert (instruction for use)Individually sealed foil pouches containing: One cassette device One desiccant 5 µL capillary tubes Sample diluent (REF SB-R0061, 5 mL/bottle) One package insert (instruction for use)Individually sealed foil pouches containing: One cassette device One desiccant 5 µL capillary tubes Sample diluent (REF SB-R0061, 5 mL/bottle) One package insert (instruction for use) CTK Products at a Glance Dengue Case Report Dengue Info for Health Care Practitioners Dengue Training Presentation Flyer Insert Poster U.S. CDC Dengue Homepage : (Clinical Guidelines, Clinical Management Tools, etc) WHO: Health Topic for Dengue